Kristin Campbell of @UBCnews explains exercise guidelines for cancer survivors limitations and safety concerns.
__________
There is growing evidence that exercise is a significant part of recovery for the increasing number of cancer survivors worldwide. But how much is required, and what kind of exercise?
A recent research study, undertaken by an international group of…
Learn about the benefits of risk-reducing surgeries in young BRCA mutation carriers with a history of breast cancer.
Get insights into the PATINA Phase 3 trial studying Palbociclib in ER+/HER2+ Metastatic Breast Cancer, and how it aims to improve outcomes in these patients.
Explore how CDK4/6 inhibitors are revolutionizing early breast cancer treatment. Find out about the expanded treatment scope and long-term efficacy.
Findings from the ZEST trial highlight the potential of ctDNA surveillance in breast cancer management. Discover the role of Niraparib in enhancing disease-free survival.
New data from DESTINY-Breast06 study presented at SABCS 2024. Explore efficacy of ENHERTU in hormone receptor-positive metastatic breast cancer patients.
Get critical insights into advanced breast cancer treatment from the Phase 3 EMBER-3 trial. Explore the efficacy of Imlunestrant and its potential in improving patient…
FDA approves combination treatment for advanced non-small cell lung cancer (NSCLC) targeting specific EGFR mutations. Learn about the MARIPOSA trial results,…
FDA approved pembrolizumab (Keytruda) combined with chemotherapy for mesothelioma treatment. A new option for patients battling this aggressive disease.
FDA approves Kisqali for early high-risk breast cancer treatment. Learn about this new treatment option and its benefits for patients.
Download Slides: https://oncologytube.com/slides-fda-approves-kisqali-ribociclib-for-early-high-risk-breast-cancer/The FDA has approved Kisqali (ribociclib) …
